DIWALI SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

KRSNAA vs LALPATHLAB: Stock Comparison

KRSNAA DIAGNOSTICS vs DR. LAL PATH LABSUpdated 13 Nov 26, 4:08 PM ISTNSE & company filings

DR. LAL PATH LABS is the larger company by market capitalisation. KRSNAA DIAGNOSTICS shows a lower P/E, while DR. LAL PATH LABS shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

KRSNAA leads 5; LALPATHLAB leads 8 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

KRSNAALALPATHLAB

Valuation lens

What price are you paying?

Market CapContext only
₹1,720 Cr
₹33,301 Cr
P/E RatioKRSNAA has the lower reading
17.54x ✓
57.01x
P/B RatioKRSNAA has the lower reading
1.66x ✓
12.11x
EPSLALPATHLAB has the higher reading
₹7.58
₹11.45 ✓
Book ValueContext only
₹302.23
₹151.4
Dividend YieldLALPATHLAB has the higher reading
0.38%
0.63% ✓

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
LALPATHLAB is the larger company
₹33,301 Cr vs ₹1,720 Cr
P/E Ratio
KRSNAA has a lower P/E
17.54x vs 57.01x
P/B Ratio
KRSNAA has a lower P/B
1.66x vs 12.11x
EPS
LALPATHLAB has higher earnings per share
₹11.45 vs ₹7.58
Dividend Yield
LALPATHLAB has a higher dividend yield
0.63% vs 0.38%
Revenue Growth (TTM YoY)
LALPATHLAB has faster revenue growth
16.6% vs 3.5%
EPS Growth (TTM YoY)
KRSNAA has faster EPS growth
102.1% vs -15.4%
Qtr Sales Growth
KRSNAA has stronger quarterly sales growth
15.05% vs 9.55%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricKRSNAALALPATHLAB
SectorHealthcareHealthcare
IndustryHealthcare Service ProviderHealthcare Service Provider

Price

MetricKRSNAALALPATHLAB
Live Price₹528.75₹1,993
Day Change2.07%-0.79%
Volume1.97 L1.45 L
52-Week High₹838₹3,309.2
52-Week Low₹463.1₹1,272.6
Distance from 52W High-36.9%-39.77%

Valuation

MetricKRSNAALALPATHLAB
Market Cap₹1,720 Cr₹33,301 Cr
P/E Ratio17.54x57.01x
P/B Ratio1.66x12.11x
EPS₹7.58₹11.45
Book Value₹302.23₹151.4
Dividend Yield0.38%0.63%

Growth

MetricKRSNAALALPATHLAB
Revenue Growth (TTM YoY)3.5%16.6%
EPS Growth (TTM YoY)102.1%-15.4%
Qtr Sales Growth15.05%9.55%
Qtr Profit Growth48.55%13.72%

Profitability & Leverage

MetricKRSNAALALPATHLAB
ROE10.35%20.06%
ROCE8.96%24.86%
Net Margin13.13%18.27%
Operating Margin21.33%25.04%
Debt to Equity0.55x0x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricKRSNAALALPATHLAB
Promoter Holding27.11%51.09%▼ 0.26 pp
FII Holding3.84%▼ 0.44 pp18.73%▲ 1.37 pp
DII Holding14.5%▼ 0.01 pp21.58%▼ 0.01 pp
Public Holding54.54%▲ 0.45 pp6.35%▼ 1.12 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: KRSNAA DIAGNOSTICS and DR. LAL PATH LABS.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.